Manuela Tutolo1, Enrico Ammirati2, Frank Van der Aa3. 1. Department of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: tutolo.manuela@hsr.it. 2. Department of Urology, Ospedale San Giovanni Battista, Turin, Italy. 3. Department of Urology, University Hospitals Leuven, Leuven, Belgium.
Abstract
We reviewed the available studies on efficacy and safety of percutaneous tibial nerve stimulation (PTNS) and sacral nerve modulation (SNM) for overactive bladder (OAB) symptoms not responsive to conservative treatments. We limited our search to randomized trials, in English, with at least 20 adult patients, and 6 mo and 12 wk of follow-up for SNM and PTNS, respectively, published between January 1998 and December 2017. Therapeutic success ranges from 61% to 90% for SNM and from 54% to 79% for PTNS. Both techniques are effective and safe, with no life-threatening adverse effects. PTNS is a less invasive technique that gives good results in short time with fewer side effects. PATIENT SUMMARY: Sacral nerve modulation and percutaneous tibial nerve stimulation are effective and safe in patients with overactive bladder syndrome not responsive to standard medical therapy.
We reviewed the available studies on efficacy and safety of percutaneous tibial nerve stimulation (PTNS) and sacral nerve modulation (SNM) for overactive bladder (OAB) symptoms not responsive to conservative treatments. We limited our search to randomized trials, in English, with at least 20 adult patients, and 6 mo and 12 wk of follow-up for SNM and PTNS, respectively, published between January 1998 and December 2017. Therapeutic success ranges from 61% to 90% for SNM and from 54% to 79% for PTNS. Both techniques are effective and safe, with no life-threatening adverse effects. PTNS is a less invasive technique that gives good results in short time with fewer side effects. PATIENT SUMMARY: Sacral nerve modulation and percutaneous tibial nerve stimulation are effective and safe in patients with overactive bladder syndrome not responsive to standard medical therapy.
Authors: Zhonghua Ouyang; Nikolas Barrera; Zachariah J Sperry; Elizabeth C Bottorff; Katie C Bittner; Lance Zirpel; Tim M Bruns Journal: Med Biol Eng Comput Date: 2022-03-29 Impact factor: 3.079